Feedback (LON:FDBK) Reaches New 1-Year Low – Should You Sell?
by Sarita Garza · The Markets DailyFeedback plc (LON:FDBK – Get Free Report) shares hit a new 52-week low on Tuesday . The stock traded as low as GBX 6.40 and last traded at GBX 6.46, with a volume of 287429 shares traded. The stock had previously closed at GBX 6.75.
Feedback Price Performance
The company has a market capitalization of £2.76 million, a PE ratio of -0.40 and a beta of 0.77. The company’s fifty day moving average is GBX 7.71 and its 200-day moving average is GBX 10.41.
About Feedback
Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.
Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.
By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.
Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.